Evaluating the Long-term Effects of Microfocused Ultrasound on Facial Tightening Using Quantitative Instruments

February 22, 2024 updated by: Hongwei Liu, First Affiliated Hospital of Jinan University

Evaluating the Long-term Effects of Microfocused Ultrasound on Facial Tightening Using Quantitative Instruments: Efficacy and Safety

By utilizing standardized photographs in conjunction with quantification detection instruments, data analysis before and after treatment is conducted, along with long-term efficacy observations. This approach aims to provide more comprehensive scientific evidence for the clinical application of ultrasound treatment in anti-aging therapy.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Primary efficacy endpoints:Utilizing the 3D Life Viz mini system for standardized photo modeling enables the comparison and identification of enhancements in treatment outcomes. This research utilized standardized photo modeling to record the facial and mandibular conditions of patients, capturing images both before and after treatment (immediately post-operation and at 7, 30, 90, and 180 days). The detection of improvements in treatment effects was then achieved through pairwise comparisons of the modeled data derived from these photographs;Secondary efficacy endpoints: Global Aesthetic Improvement Scale, patient satisfaction scores, Digital Visual Analog Scale

Study Type

Observational

Enrollment (Estimated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Recruiting
        • First Affiliated Hospital of Jinan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy women who age naturally

Description

Inclusion Criteria:

  1. Ages between 25 and 60 years old.
  2. Clear manifested skin issues such as sagging and wrinkles: Merz Facial Aesthetics Score of 2 or above.
  3. Absence of significant systemic diseases, cardiovascular disorders, impaired liver or kidney function, malignant tumors, etc.
  4. Willing to participate in this study and sign an informed consent form.

Exclusion Criteria:

  1. Pregnant or lactating women.
  2. Individuals with a scar-prone constitution, allergic or abnormally healing skin.
  3. Treatment areas with damaged skin, acute inflammation, active infection, rosacea, vitiligo in the progressive stage, or severe acne.
  4. Patients with skin conditions such as urticaria, itching, or other dermatological diseases.
  5. Those with psychological disorders or drug allergies.
  6. Individuals harboring unrealistic expectations about treatment outcomes.
  7. Treatment areas containing metal foreign bodies or fillers deemed unsuitable for treatment by the physician.
  8. Recent facial laser treatments or injections within the past month, including but not limited to filler treatments such as hyaluronic acid, botulinum toxin, and PRP injection therapy.
  9. Any skin-tightening cosmetic treatments on the face or neck within the last three months.
  10. Any minimally invasive cosmetic treatments on the face within the last three months.
  11. Thread embedding treatments on the face within the last year, excluding thread blepharoplasty.
  12. Patients with severe insomnia or those requiring intense sun exposure within the next three months.
  13. Patients deemed unsuitable for participation by the investigator.
  14. Those unable to cooperate with the treatment and complete all required visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Volume Change of Nasolabial Folds
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days
Change in Maximum Depth of Nasolabial Folds
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days
Vertical Elevation Value of Nasolabial Fold Curve Projection Curve
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days
Elevation Value of Nasolabial Fold Curve Projection Curve (Along the Nasal Wing Method
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days
Change in Mid-Facial Volume
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days
Brow Lift Height
Time Frame: 30、90、180 days
Utilizing the 3D Life Viz mini system for capturing images both before and after treatment by 30、90、180 days;
30、90、180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hongwei LIU, First Affiliated Hospital of Jinan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2023

Primary Completion (Estimated)

September 15, 2024

Study Completion (Estimated)

March 15, 2025

Study Registration Dates

First Submitted

February 22, 2024

First Submitted That Met QC Criteria

February 22, 2024

First Posted (Estimated)

February 29, 2024

Study Record Updates

Last Update Posted (Estimated)

February 29, 2024

Last Update Submitted That Met QC Criteria

February 22, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LEMU47

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Facial Aging

3
Subscribe